Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Comment by biggdoggon Jan 12, 2023 5:46pm
124 Views
Post# 35219762

RE:Not just the Barite

RE:Not just the BariteThe PEA had $70M a year barite revenue, correct me if I am wrong, using my old memory. Postie is correct, iodine is 10-20 fold the revenue, and when you have barium to add to iodine, the sales are much easier for both, hence why Bracco has monopoly on barium. Its all about iodine.  And Voy has a major DISRUPTOR in the que, CARBON CONTRAST. look out, this story will continue to grow into the most talked about stock in the last ten years once those sleeping wake up. Once they fully integrate iodine, this will be a $10 stock. The carbon contrast will add $3-4 down the road. And carbon neutral checking off the ESG checkmarks, this will become a very popular stock.
<< Previous
Bullboard Posts
Next >>